Abstract
ThyroidVol. 21, No. 9 Editorials and CommentaryThyroid Targeted KrasG12D/Pten−/− Mice and Their Cell Lines: New Tools to Study Thyroid Cancer BiologyRebecca E. Schweppe and Bryan R. HaugenRebecca E. SchweppeSearch for more papers by this author and Bryan R. HaugenSearch for more papers by this authorPublished Online:30 Aug 2011https://doi.org/10.1089/thy.2011.2109.edAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byLong-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model26 April 2016 | Oncotarget, Vol. 7, No. 21 Volume 21Issue 9Sep 2011 InformationCopyright 2011, Mary Ann Liebert, Inc.To cite this article:Rebecca E. Schweppe and Bryan R. Haugen.Thyroid Targeted KrasG12D/Pten−/− Mice and Their Cell Lines: New Tools to Study Thyroid Cancer Biology.Thyroid.Sep 2011.941-944.http://doi.org/10.1089/thy.2011.2109.edPublished in Volume: 21 Issue 9: August 30, 2011PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
